Russell Investments Group
DSGN icon

Russell Investments Group’s Design Therapeutics DSGN Stock Holding History

Russell Investments Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967K Buy
66,859
+41,422
+163% +$516K ﹤0.01% 2478
2026
Q1 		$271K Buy
25,437
+203
+0.8% +$2.05K ﹤0.01% 2744
2025
Q4 		$237K Buy
25,234
+18,857
+296% +$148K ﹤0.01% 2779
2025
Q3 		$48K Buy
6,377
+2,618
+70% +$13.1K ﹤0.01% 3309
2025
Q2 		$12.7K Sell
3,759
-181
-5% -$677 ﹤0.01% 3282
2025
Q1 		$15.2K Buy
3,940
+881
+29% +$4.2K ﹤0.01% 3159
2024
Q4 		$18.9K Sell
3,059
-1,433
-32% -$8.29K ﹤0.01% 3021
2024
Q3 		$24.2K Sell
4,492
-3,752
-46% -$17.6K ﹤0.01% 2918
2024
Q2 		$27.6K Buy
8,244
+3,933
+91% +$15.3K ﹤0.01% 2885
2024
Q1 		$17.4K Buy
4,311
+2,447
+131% +$6.54K ﹤0.01% 2789
2023
Q4 		$4.94K Buy
1,864
+1,251
+204% +$2.87K ﹤0.01% 2908
2023
Q3 		$1.45K Sell
613
-781
-56% -$3.64K ﹤0.01% 3300
2023
Q2 		$8.78K Buy
1,394
+402
+41% +$2.46K ﹤0.01% 2989
2023
Q1 		$5.72K Hold
992
– – ﹤0.01% 2937
2022
Q4 		$10.2K Hold
992
– – ﹤0.01% 2844
2022
Q3 		$16K Sell
992
-1,352
-58% -$26.9K ﹤0.01% 2827
2022
Q2 		$32K Buy
+2,344
New +$31.7K ﹤0.01% 2758

Other funds holding DSGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's DSGN Position: Q2 2026 in Review

Russell Investments Group increased its Design Therapeutics (DSGN) stake by 163% in Q2 2026, buying an estimated $516K and bringing the position to 66,859 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Russell Investments Group first reported a position in DSGN in Q2 2022 and has held it in 17 quarters since. 40 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Russell Investments Group held 66,859 shares of Design Therapeutics worth $967K as of Q2 2026.
  • Russell Investments Group bought 41,422 Design Therapeutics shares in Q2 2026, an estimated $516K.
  • Design Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2478 holding.
  • Russell Investments Group first reported a position in Design Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 40 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.